Predicting functional decline and survival in amyotrophic lateral sclerosis

Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis

(2016) M. K. Rafiq et al.   EUROPEAN JOURNAL OF NEUROLOGY

Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase

(2015) Alexandre Henriques et al.   HUMAN MOLECULAR GENETICS

Stratification of ALS patients’ survival: a population-based study

(2015) Benoît Marin et al.   JOURNAL OF NEUROLOGY

Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?

(2015) Neta Zach et al.   Neurotherapeutics

Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression

(2014) Robert Küffner et al.   NATURE BIOTECHNOLOGY

The PRO-ACT database: Design, initial analyses, and predictive features

(2014) N. Atassi et al.   NEUROLOGY

Amyotrophic Lateral Sclerosis Outcome Measures and the Role of Albumin and Creatinine

(2014) Adriano Chiò et al.   JAMA Neurology

The changing scene of amyotrophic lateral sclerosis

(2013) Wim Robberecht et al.   NATURE REVIEWS NEUROSCIENCE

Amyotrophic lateral sclerosis disease progression model

(2013) Roberto Gomeni et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

The Multiple Faces of Valosin-Containing Protein-Associated Diseases: Inclusion Body Myopathy with Paget’s Disease of Bone, Frontotemporal Dementia, and Amyotrophic Lateral Sclerosis

(2011) Angèle Nalbandian et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis

(2011) Sabrina Paganoni et al.   MUSCLE & NERVE

Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis

(2010) J. Dorst et al.   JOURNAL OF NEUROLOGY